Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report

Plasma cell disorders (PCDs) are identified in the clinical lab by detecting the monoclonal immunoglobulin (M-protein) which they produce. Traditionally, serum protein electrophoresis methods have been utilized to detect and isotype M-proteins. Increasing demands to detect low-level disease and new...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, David L., Puig, Noemi, Kristinsson, Sigurdur, Usmani, Saad Z., Dispenzieri, Angela, Bianchi, Giada, Kumar, Shaji, Chng, Wee Joo, Hajek, Roman, Paiva, Bruno, Waage, Anders, Rajkumar, S. Vincent, Durie, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873248/
https://www.ncbi.nlm.nih.gov/pubmed/33563895
http://dx.doi.org/10.1038/s41408-021-00408-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873248/
https://www.ncbi.nlm.nih.gov/pubmed/33563895
http://dx.doi.org/10.1038/s41408-021-00408-4

Ejemplares similares